A Look At CNO Financial Group (CNO) Valuation After Recent Mixed Short Term Share Price Moves

CNO Financial Group, Inc. -0.44%

CNO Financial Group, Inc.

CNO

42.98

-0.44%

How CNO Financial Group stock has been performing

CNO Financial Group (CNO) has drawn attention after a period of mixed short term returns, with the share price slightly lower over the past week but higher over the past month and past 3 months.

At a recent close of $43.06, the insurer’s stock sits above its year to date level and its 1 year total return. Multi year total returns are also available for investors to compare against shorter term moves.

For CNO Financial Group, momentum has softened recently, with a 7 day share price return of a 3.54% decline and a 30 day share price return of a 1.48% gain, set against a 5 year total shareholder return of 101.36%.

If this kind of long term compounding has your attention, it could be a good moment to widen your search and check out 23 top founder-led companies as potential next ideas.

CNO now trades at $43.06 with an analyst price target of $48 and an estimated intrinsic value gap of about 39%. Is this a genuine value opportunity, or is the market already baking in future growth?

Most Popular Narrative: 8.9% Undervalued

Compared with the last close at $43.06, the most followed narrative points to a fair value of $47.25, using a consistent set of long term assumptions.

Analysts expect earnings to reach $432.2 million (and earnings per share of $4.91) by about September 2028, up from $288.7 million today. The analysts are largely in agreement about this estimate.

Curious what kind of profit margin shift is baked into that valuation, and how much multiple compression it assumes? The full narrative spells out those moving parts in detail.

Result: Fair Value of $47.25 (UNDERVALUED)

However, this narrative could be challenged if interest rates stay low and compress investment margins, or if long term care claims rise and pressure profitability.

Another View: Earnings Multiple Sends A Different Signal

Our DCF model points to upside, but the simple earnings multiple tells a different story. CNO trades on a P/E of 17.7x, compared with 12.3x for the US insurance industry, 9.5x for peers, and a fair ratio of 16x that the market could move toward. That higher starting point can limit room for error, so which signal do you think deserves more weight?

NYSE:CNO P/E Ratio as at Feb 2026
NYSE:CNO P/E Ratio as at Feb 2026

Build Your Own CNO Financial Group Narrative

If you look at these numbers and come to a different conclusion, or simply prefer to test your own assumptions, you can build a full CNO story in just a few minutes using Do it your way.

A great starting point for your CNO Financial Group research is our analysis highlighting 3 key rewards and 4 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If CNO has sharpened your thinking, do not stop here. Broaden your watchlist with a few focused stock ideas that could sharpen your next move.

  • Target resilient income by scanning companies that feature 13 dividend fortresses built around higher yields that many investors overlook.
  • Hunt for quality at a sensible price with 53 high quality undervalued stocks, so you are not relying on gut feel alone when you compare opportunities.
  • Prioritise peace of mind by reviewing 85 resilient stocks with low risk scores, where companies are filtered for lower overall risk scores before you commit fresh capital.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.